FDA Drug Application (020835) for ACTONEL by APIL

Back to FDA Applications sponsored by APIL

Application Number020835
Product Number001
FormTABLET;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameACTONEL
Active IngredientRISEDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient RISEDRONATE SODIUM4


Back to FDA Applications sponsored by APIL